Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments
University of Michigan · Aarhus University Hospital · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
335
total citations
- FWCI
- 34.09
- Percentile
- 100%
- References
- 115
Citations per year
Authors
7Topics & keywords
Topics
Keywords
- Medicine
- Type 2 diabetes
- Peripheral neuropathy
- Diabetes mellitus
- Quality of life (healthcare)
- Risk factor
- Intensive care medicine
- Pathophysiology
No related works found for this paper.
Funding
- UDU.S. Department of Veterans Affairs
- JDJuvenile Diabetes Research Foundation InternationalAward: 5COE-2019–861-S-B
- AAmgen
- ELEli Lilly and CompanyAward: MR/W002388/1
- AAstraZeneca
- AAAmerican Academy of Neurology
- AAA. Alfred Taubman Medical Research Institute
- RPRegeneron Pharmaceuticals
- URUK Research and Innovation
- SMSinai Medical Staff Foundation
- VMVirginia Marine Resources CommissionAward: MR/T020113/1
- DUDiabetes UKAward: 19/0005984
- NNNovo NordiskAward: NNF14OC0011633
- NNNovo Nordisk FondenAwards: NNF14OC0011633, NFOC140011633
- NINational Institutes of HealthAwards: DK089503, R24DK082841, 5R25NS089450, R21NS102924, R01DK115687, UL1TR002240, R01DK129320
- MRMedical Research CouncilAwards: MR/W002388/1, MR/T020113/1, MR/T020113/1
- BABiotechnology and Biological Sciences Research CouncilAward: BB/S006788/1
- NINational Institute of Diabetes and Digestive and Kidney DiseasesAwards: R01DK129320, UL1TR002240, P30-DK-02926, DK089503, P30-DK089503, R01DK115687, R24DK082841
- NINational Institute of Neurological Disorders and StrokeAwards: 5R25NS089450, NNF14OC0011633, R21NS102924
- NCNational Center for Advancing Translational SciencesAward: UL1TR002240